- 30 April 2025
- 17 April 2025
The white paper ‘Antibiotic therapy: everyone's business’ is the result of fruitful discussions between professionals in the sector during a conference-debate and a temporary think tank in June and September 2024.
< ...
Young people can play an important role in combating antimicrobial resistance (AMR) by bringing together society as a whole and stakeholder groups.
On 25 March 2025, six organisations – the Food and Agriculture Org ...
Fungal diseases are an increasingly worrying public health issue, with common infections – oral and vaginal thrush – becoming increasingly resistant to treatment. These infections disproportionately affect seriously ill patients and those with weakened immune systems, including people underg ...
- 28 March 2025
The recently published OZAVIE observational study confirms that the combination of ceftazidime and avibactam (CAZ-AVI) is effective, with a clinical success rate ranging from 63.4% to 79% in the treatment of multidrug-resistant Gram-negative (MDR-GNB) infections. These rates increase from 65.6% ...
On 5 March, the WHO published a document entitled ‘The case for investment and action in infection prevention and control’. This document provides data on the expected return on investment and gu ...
The World Health Organisation (WHO) has published a global research agenda on antimicrobial resistance in human health, aimed at generating evidence to combat AMR in human health by 2030. This programme identifies 33 research priorities on bacterial and fungal infections, as well as seven priori ...